Ginkgo Bioworks (DNA) to Release Earnings on Tuesday

Ginkgo Bioworks (NYSE:DNA) is expected to be issuing its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of ($1.45) per share and revenue of $44.43 million for the quarter.

Ginkgo Bioworks Trading Down 9.7 %

DNA stock opened at $11.45 on Friday. The business has a 50-day moving average price of $11.45. Ginkgo Bioworks has a 12-month low of $5.26 and a 12-month high of $64.40. The firm has a market cap of $657.86 million, a PE ratio of -0.88 and a beta of 1.16.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.